PAPER Shen B, Pan Y, Jiang X, Wu Z, Zhu J, Dong J, Zhang W, Xu P, Dai Y, Gao Y, Xiao C, Zhang L

Altered putamen and cerebellum connectivity among different subtypes of Parkinson's disease.

CNS Neurosci Ther. 2019 Nov 15; PubMed: 31730272

PAPER Chiarotto GB, Cartarozzi LP, Perez M, Biscola NP, Spejo AB, Gubert F, França Junior M, Mendez-Otero R, de Oliveira AL

Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS.

J Neuroinflammation. 2019 Nov 14;16(1):218. PubMed: 31727149

PAPER Ganjam GK, Bolte K, Matschke LA, Neitemeier S, Dolga AM, Höllerhage M, Höglinger GU, Adamczyk A, Decher N, Oertel WH, Culmsee C

Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons.

Cell Death Dis. 2019 Nov 14;10(11):865. PubMed: 31727879

PAPER Tampi RR, Young JJ, Tampi D

Behavioral symptomatology and psychopharmacology of Lewy body dementia.

Handb Clin Neurol. 2019;165:59-70. PubMed: 31727230

PAPER Fabbrini G, Fabbrini A, Suppa A

Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.

Handb Clin Neurol. 2019;165:155-177. PubMed: 31727210

PAPER Al-Chalabi A, Heunks LM, Papp Z, Pollesello P

Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis.

J Cardiovasc Pharmacol. 2019 Nov;74(5):389-399. PubMed: 31730560

PAPER de Jong J, Emon MA, Wu P, Karki R, Sood M, Godard P, Ahmad A, Vrooman H, Hofmann-Apitius M, Fröhlich H

Deep learning for clustering of multivariate clinical patient trajectories with missing values.

Gigascience. 2019 Nov 1;8(11) PubMed: 31730697

PAPER Zhou Y, Liyanage PY, Devadoss D, Rios Guevara LR, Cheng L, Graham RM, Chand HS, Al-Youbi AO, Bashammakh AS, El-Shahawi MS, Leblanc RM

Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid.

Nanoscale. 2019 Nov 28;11(46):22387-22397. PubMed: 31730144

PAPER Soukup O, Korabecny J

Editorial: Multi Target- Directed Ligands in the Treatment of Alzheimer's Disease.

Curr Alzheimer Res. 2019;16(9):771. PubMed: 31729288

PAPER Yuyama K, Takahashi K, Usuki S, Mikami D, Sun H, Hanamatsu H, Furukawa J, Mukai K, Igarashi Y

Plant sphingolipids promote extracellular vesicle release and alleviate amyloid-β pathologies in a mouse model of Alzheimer's disease.

Sci Rep. 2019 Nov 14;9(1):16827. PubMed: 31727994

PAPER Zhu H, Tang Z, Cheng H, Wu Y, Fan Y

Multi-atlas label fusion with random local binary pattern features: Application to hippocampus segmentation.

Sci Rep. 2019 Nov 14;9(1):16839. PubMed: 31727982

PAPER Kim DK, Han D, Park J, Choi H, Park JC, Cha MY, Woo J, Byun MS, Lee DY, Kim Y, Mook-Jung I

Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.

Exp Mol Med. 2019 Nov 15;51(11):136. PubMed: 31727875

PAPER Deardorff WJ, Grossberg GT

Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.

Handb Clin Neurol. 2019;165:5-32. PubMed: 31727229

PAPER Ben-Nejma IR, Keliris AJ, Daans J, Ponsaerts P, Verhoye M, Van der Linden A, Keliris GA

Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis.

Acta Neuropathol Commun. 2019 Nov 14;7(1):180. PubMed: 31727182

PAPER Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CA, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith AP, Kumar S, Farrar G, Walter J

Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.

Acta Neuropathol Commun. 2019 Nov 14;7(1):178. PubMed: 31727169